Sandoz, a Novartis division, announced today that it extended and expanded a strategic collaboration agreement with Ares Genetics. Basel, Switzerland-baed Sandoz’s collaboration with Ares, aimed at driving innovation to develop solutions in the fight against antimicrobial resistance (AMR), was extended through January 31, 2025. According to a news release, the companies agreed to an extension…